Clinical Edge Journal Scan

Sleep and migraine: What is the link?


 

Key clinical point: Poor sleep could be a significant risk factor for an ensuing migraine attack, and an intensely painful migraine attack may lead to a subsequent increase in sleep duration, thus highlighting that sleep hygiene is an inherent part of migraine management.

Major finding: The odds of having a migraine attack increased by 6.1% and 17.4% with every deviation from mean sleep and every sleep interruption, respectively, during the previous day, whereas the overall sleep duration had no effect on attack occurrences. An intensely painful attack (M = 0.13; 95% high density interval 0.06-0.20) positively predicted increased sleep duration during the same evening.

Study details: This retrospective cross-sectional study included 724 patients (ages, 18 -81 years) with a mean monthly migraine attack frequency of 9.94.

Disclosures: This study was supported by a UK Medical Research Council PhD studentship. Two authors declared being employees of Healint Pte. Ltd, and some authors declared ties with various sources.

Source: Stanyer EC et al. Investigating the relationship between sleep and migraine in a global sample: A Bayesian cross-sectional approach. J Headache Pain. 2023;24:123 (Sep 8). doi: 10.1186/s10194-023-01638-6

Recommended Reading

Migraine history and COVID-19 risk in older women: Is there a link?
Migraine ICYMI
Responders to anti-CGRP mAb show improvement in migraine-attack-associated symptoms
Migraine ICYMI
Fremanezumab reduces medication overuse in chronic migraine
Migraine ICYMI
Commentary: "Migraine Plus" Symptoms, October 2023
Migraine ICYMI
Are migraine preventives underused in young adults?
Migraine ICYMI
Intravenous dihydroergotamine safe in refractory chronic migraine regardless of cardiovascular risk
Migraine ICYMI
Benefits of low-dose thyroid replacement in migraine with subclinical hypothyroidism
Migraine ICYMI
Cutaneous allodynia and aura play significant roles in CGRP-induced migraine attacks
Migraine ICYMI
Triptan non-response tied to increased migraine severity
Migraine ICYMI
Chronic migraine and multiple treatment failures predict poor response to galcanezumab
Migraine ICYMI